LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "systemic agents" as a keyword



Safety of Systemic Agents for the Treatment of Pediatric Psoriasis

Sign Up to like & get
recommendations! Published in 2017 at "JAMA Dermatology"

DOI: 10.1001/jamadermatol.2017.3029

Abstract: Importance Use of systemic therapies for moderate to severe psoriasis in children is increasing, but comparative data on their use and toxicities are limited. Objective To assess patterns of use and relative risks of systemic… read more here.

Keywords: folic acid; methotrexate; treatment; systemic agents ... See more keywords

Psoriasis Risk in Patients With Atopic Dermatitis Treated With Dupilumab.

Sign Up to like & get
recommendations! Published in 2025 at "JAMA dermatology"

DOI: 10.1001/jamadermatol.2025.1578

Abstract: Importance Patients with atopic dermatitis (AD) have been reported to develop psoriasis during dupilumab treatment. Whether this represents a true association or an incidental event remains unclear. Objective To compare psoriasis risk in patients with… read more here.

Keywords: cohort; patients atopic; systemic agents; risk ... See more keywords
Photo from wikipedia

Role of locoregional therapies in the wake of systemic therapy.

Sign Up to like & get
recommendations! Published in 2020 at "Journal of hepatology"

DOI: 10.1016/j.jhep.2019.09.023

Abstract: Multiple systemic agents have recently been approved in the first- and second-line setting for hepatocellular carcinoma (HCC), increasing the therapeutic options for patients and treating physicians. The randomised controlled trials that led to these approvals… read more here.

Keywords: systemic therapy; systemic agents; role locoregional; locoregional therapies ... See more keywords

Resistance to Systemic Agents in Renal Cell Carcinoma Predict and Overcome Genomic Strategies Adopted by Tumor

Sign Up to like & get
recommendations! Published in 2019 at "Cancers"

DOI: 10.3390/cancers11060830

Abstract: The development of new systemic agents has led us into a “golden era” of management of metastatic renal cell carcinoma (RCC). Certainly, the approval of immune-checkpoint inhibitors and the combination of these with targeted compounds… read more here.

Keywords: renal cell; resistance systemic; cell carcinoma; systemic agents ... See more keywords